Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Skin Melanoma”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Not applicableLooking for participantsNCT05837767
What this trial is testing

Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Who this might be right for
Invasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more
Memorial Sloan Kettering Cancer Center 26
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Not applicableUnknownNCT05223218
What this trial is testing

Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study

Who this might be right for
Breast CancerOvarian CancerPancreatic Cancer+2 more
Namida Lab 500
Large-scale testing (Phase 3)Study completedNCT00275496
What this trial is testing

Multicenter Selective Lymphadenectomy Trial (MSLT)

Who this might be right for
Melanoma
Saint John's Cancer Institute 2,001
Not applicableLooking for participantsNCT05196087
What this trial is testing

Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)

Who this might be right for
Breast CancerMelanomaGastrointestinal Neuroendocrine Tumor
University Health Network, Toronto 500
Not applicableStudy completedNCT03638492
What this trial is testing

Trial of Surgical Excision Margins in Thick Primary Melanoma - 2

Who this might be right for
MelanomaSurgeryTreatment Outcome
Peter Gillgren 936
Early research (Phase 1)Ended earlyNCT06448364
What this trial is testing

A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination

Who this might be right for
Advanced or Metastatic Solid TumorsNon-Small Cell Lung CancerColorectal Cancer+2 more
Pfizer 4
Not applicableLooking for participantsNCT05059444
What this trial is testing

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Who this might be right for
Bladder CarcinomaUreter CarcinomaRenal Pelvis Carcinoma+13 more
Guardant Health, Inc. 2,020
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Not applicableStudy completedNCT06221397
What this trial is testing

Clinical Validation Study of an AI-based CAD System for Early Non-Invasive Detection of Cutaneous Melanoma

Who this might be right for
MelanomaMelanoma, Skin
AI Labs Group S.L 200
Testing effectiveness (Phase 2)Ended earlyNCT02587650
What this trial is testing

Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma

Who this might be right for
ALK Fusion Protein ExpressionBRAF wt AlleleInvasive Skin Melanoma+12 more
University of California, San Francisco 1
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableLooking for participantsNCT06605404
What this trial is testing

Pan-tumor MRD Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more
Paradigm Health 1,350
Not applicableStudy completedNCT02056522
What this trial is testing

Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging

Who this might be right for
Skin Lesions
Orlucent, Inc 357
Not applicableLooking for participantsNCT07318051
What this trial is testing

Sample Collection for Ongoing Research and Product Evaluation Study

Who this might be right for
Breast CancerLung CancerMuscle Invasive Bladder Cancer+9 more
Natera, Inc. 9,600
Not applicableStudy completedNCT01500304
What this trial is testing

Minimally Invasive Groin Dissection for Melanoma

Who this might be right for
Melanoma
Mayo Clinic 88
Not applicableLooking for participantsNCT06605443
What this trial is testing

Precision Medicine for L/GCMN and Melanoma 2

Who this might be right for
Melanoma (Skin Cancer)Nevi and MelanomasCongenital Melanocytic Nevus
Fundacion Clinic per a la Recerca Biomédica 100
Not applicableEnded earlyNCT00482105
What this trial is testing

Early Diagnosis of Melanoma Using Expression Profiling and Non-Invasive Sampling of Skin Cells

Who this might be right for
Melanoma
University of California, Davis 7
Testing effectiveness (Phase 2)Ended earlyNCT05012397
What this trial is testing

Milademetan in Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorsHead and Neck CarcinomaCholangiocarcinoma+15 more
Rain Oncology Inc 40
Not applicableLooking for participantsNCT04314401
What this trial is testing

National Cancer Institute "Cancer Moonshot Biobank"

Who this might be right for
Acute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more
National Cancer Institute (NCI) 1,600
Load More Results